Form 4: Inmune Bio CFO David Moss Increases Stake with $52,868 Stock Purchase

David Moss, CFO of Inmune Bio, Inc., acquired 10,000 shares of common stock at $5.2868 per share on September 30, 2024, increasing his direct holdings to 1,285,869 shares.

Summary

• On September 30, 2024, David Moss, the Chief Financial Officer of Inmune Bio, Inc. (INMB), purchased 10,000 shares of the company's common stock.
• The purchase price was $5.2868 per share, totaling $52,868.
• Following this transaction, Moss directly owns 1,285,869 shares of Inmune Bio, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CFO's purchase suggests confidence, but it's a single transaction and doesn't guarantee future performance.

Positives

• The CFO's purchase of company stock could be interpreted as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. These filings are closely watched by investors for signals about management's confidence in the company.

Stakeholder Impact

• The stock purchase could have a minor positive impact on shareholder sentiment.

Key Dates